471 related articles for article (PubMed ID: 10541269)
21. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
[TBL] [Abstract][Full Text] [Related]
22. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of stone formation.
Worcester EM
Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
[TBL] [Abstract][Full Text] [Related]
24. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs.
Li S; Macaringue EGJ; Zhou D; Shi P; Tang W; Gong J
J Ethnopharmacol; 2022 Feb; 284():114733. PubMed ID: 34644589
[TBL] [Abstract][Full Text] [Related]
25. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
Worcester EM; Nakagawa Y; Coe FL
Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
[TBL] [Abstract][Full Text] [Related]
26. Identification of bikunin isolated from human urine inhibits calcium oxalate crystal growth and its localization in the kidneys.
Okuyama M; Yamaguchi S; Yachiku S
Int J Urol; 2003 Oct; 10(10):530-5. PubMed ID: 14516400
[TBL] [Abstract][Full Text] [Related]
27. A simple procedure for isolating microgram quantities of biologically active bikunin from human urine.
Yang L; Resnick MI; Marengo SR
BJU Int; 2005 Sep; 96(4):647-53. PubMed ID: 16104926
[TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
Suzuki K; Tsugawa R
Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
[TBL] [Abstract][Full Text] [Related]
29. Role of inter-alpha-inhibitor and its related proteins in urolithiasis. Purification of an inter-alpha-inhibitor related protein from the bovine kidney.
Atmani F; Khan SR
Urol Res; 1999; 27(1):57-61. PubMed ID: 10092154
[TBL] [Abstract][Full Text] [Related]
30. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
Coe FL; Nakagawa Y; Asplin J; Parks JH
Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
[TBL] [Abstract][Full Text] [Related]
31. Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro.
Atmani F; Khan SR
BJU Int; 2000 Apr; 85(6):621-5. PubMed ID: 10759652
[TBL] [Abstract][Full Text] [Related]
32. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
33. Expression of bikunin mRNA in renal epithelial cells after oxalate exposure.
Iida S; Peck AB; Byer KJ; Khan SR
J Urol; 1999 Oct; 162(4):1480-6. PubMed ID: 10492241
[TBL] [Abstract][Full Text] [Related]
34. Analysis of glycosaminoglycans induced in newly formed calcium oxalate crystals using an undiluted urine system.
Suzuki K; Tsugawa R
Scanning Microsc; 1995; 9(4):1089-95; discussion 1095-6. PubMed ID: 8819890
[TBL] [Abstract][Full Text] [Related]
35. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid.
Wesson JA; Worcester E
Scanning Microsc; 1996; 10(2):415-23; 423-4. PubMed ID: 9813620
[TBL] [Abstract][Full Text] [Related]
36. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
Suzuki K; Mayne K; Doyle IR; Ryall RL
Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
[TBL] [Abstract][Full Text] [Related]
37. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
[TBL] [Abstract][Full Text] [Related]
38. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules.
Wesson JA; Worcester EM; Wiessner JH; Mandel NS; Kleinman JG
Kidney Int; 1998 Apr; 53(4):952-7. PubMed ID: 9551403
[TBL] [Abstract][Full Text] [Related]
39. The crystal structure of bikunin from the inter-alpha-inhibitor complex: a serine protease inhibitor with two Kunitz domains.
Xu Y; Carr PD; Guss JM; Ollis DL
J Mol Biol; 1998 Mar; 276(5):955-66. PubMed ID: 9566199
[TBL] [Abstract][Full Text] [Related]
40. Mass spectrometric identification of human phosphate cytidylyltransferase 1 as a novel calcium oxalate crystal growth inhibitor purified from human renal stone matrix.
Priyadarshini ; Singh SK; Tandon C
Clin Chim Acta; 2009 Oct; 408(1-2):34-8. PubMed ID: 19595683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
